Bromine in PDB 1gsz: Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Enzymatic activity of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
All present enzymatic activity of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071:
5.4.99.17;
Protein crystallography data
The structure of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071, PDB code: 1gsz
was solved by
A.Lenhart,
W.A.Weihofen,
A.E.W.Pleschke,
G.E.Schulz,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
25.00 /
2.80
|
Space group
|
P 32 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
140.897,
140.897,
244.049,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
20.3 /
25.9
|
Other elements in 1gsz:
The structure of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 also contains other interesting chemical elements:
Bromine Binding Sites:
The binding sites of Bromine atom in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
(pdb code 1gsz). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 6 binding sites of Bromine where determined in the
Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071, PDB code: 1gsz:
Jump to Bromine binding site number:
1;
2;
3;
4;
5;
6;
Bromine binding site 1 out
of 6 in 1gsz
Go back to
Bromine Binding Sites List in 1gsz
Bromine binding site 1 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br1630
b:55.5
occ:0.62
|
BR23
|
A:R711630
|
0.0
|
55.5
|
0.6
|
BR23
|
A:R711630
|
0.9
|
50.3
|
0.4
|
C11
|
A:R711630
|
1.7
|
50.3
|
0.4
|
C11
|
A:R711630
|
1.9
|
55.5
|
0.6
|
C12
|
A:R711630
|
2.5
|
50.3
|
0.4
|
C10
|
A:R711630
|
2.7
|
50.3
|
0.4
|
C12
|
A:R711630
|
2.8
|
55.5
|
0.6
|
C10
|
A:R711630
|
2.9
|
55.5
|
0.6
|
C13
|
A:R711630
|
3.8
|
50.3
|
0.4
|
CA
|
A:ALA170
|
3.8
|
22.0
|
1.0
|
C9
|
A:R711630
|
4.0
|
50.3
|
0.4
|
CB
|
A:ALA170
|
4.0
|
26.1
|
1.0
|
C13
|
A:R711630
|
4.2
|
55.5
|
0.6
|
C9
|
A:R711630
|
4.2
|
55.5
|
0.6
|
CG2
|
A:VAL440
|
4.3
|
20.5
|
1.0
|
CZ
|
A:PHE129
|
4.4
|
24.5
|
1.0
|
O
|
A:HOH2053
|
4.4
|
13.0
|
1.0
|
C8
|
A:R711630
|
4.4
|
50.3
|
0.4
|
O
|
A:ALA170
|
4.7
|
22.0
|
1.0
|
CD1
|
A:TRP169
|
4.7
|
12.0
|
1.0
|
CE2
|
A:PHE129
|
4.7
|
24.5
|
1.0
|
C8
|
A:R711630
|
4.7
|
55.5
|
0.6
|
C
|
A:ALA170
|
4.8
|
22.0
|
1.0
|
N
|
A:ALA170
|
4.8
|
22.0
|
1.0
|
CE2
|
A:PHE434
|
4.8
|
51.3
|
1.0
|
O
|
A:GLU439
|
4.8
|
83.9
|
1.0
|
CB
|
A:THR173
|
4.8
|
24.2
|
1.0
|
OG1
|
A:THR173
|
4.8
|
24.2
|
1.0
|
|
Bromine binding site 2 out
of 6 in 1gsz
Go back to
Bromine Binding Sites List in 1gsz
Bromine binding site 2 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br1630
b:50.3
occ:0.38
|
BR23
|
A:R711630
|
0.0
|
50.3
|
0.4
|
BR23
|
A:R711630
|
0.9
|
55.5
|
0.6
|
C11
|
A:R711630
|
1.9
|
50.3
|
0.4
|
C11
|
A:R711630
|
2.4
|
55.5
|
0.6
|
C10
|
A:R711630
|
2.9
|
50.3
|
0.4
|
C12
|
A:R711630
|
2.9
|
50.3
|
0.4
|
C12
|
A:R711630
|
3.3
|
55.5
|
0.6
|
C10
|
A:R711630
|
3.3
|
55.5
|
0.6
|
CZ
|
A:PHE129
|
3.7
|
24.5
|
1.0
|
CE2
|
A:PHE434
|
3.9
|
51.3
|
1.0
|
C9
|
A:R711630
|
4.2
|
50.3
|
0.4
|
C13
|
A:R711630
|
4.2
|
50.3
|
0.4
|
CE2
|
A:PHE129
|
4.2
|
24.5
|
1.0
|
O
|
A:HOH2053
|
4.2
|
13.0
|
1.0
|
CA
|
A:ALA170
|
4.3
|
22.0
|
1.0
|
CB
|
A:THR173
|
4.5
|
24.2
|
1.0
|
CG2
|
A:THR173
|
4.5
|
24.2
|
1.0
|
CB
|
A:ALA170
|
4.6
|
26.1
|
1.0
|
C13
|
A:R711630
|
4.6
|
55.5
|
0.6
|
C9
|
A:R711630
|
4.6
|
55.5
|
0.6
|
O
|
A:ALA170
|
4.7
|
22.0
|
1.0
|
OG1
|
A:THR173
|
4.7
|
24.2
|
1.0
|
CD2
|
A:PHE434
|
4.7
|
51.3
|
1.0
|
CE1
|
A:PHE129
|
4.7
|
24.5
|
1.0
|
CZ
|
A:PHE434
|
4.8
|
51.3
|
1.0
|
C8
|
A:R711630
|
4.8
|
50.3
|
0.4
|
CG2
|
A:VAL440
|
4.8
|
20.5
|
1.0
|
O
|
A:HOH2052
|
4.8
|
27.8
|
1.0
|
|
Bromine binding site 3 out
of 6 in 1gsz
Go back to
Bromine Binding Sites List in 1gsz
Bromine binding site 3 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br1630
b:49.6
occ:0.62
|
BR23
|
B:R711630
|
0.0
|
49.6
|
0.6
|
BR23
|
B:R711630
|
1.0
|
33.6
|
0.4
|
C11
|
B:R711630
|
1.9
|
49.6
|
0.6
|
C11
|
B:R711630
|
2.0
|
33.6
|
0.4
|
C12
|
B:R711630
|
2.8
|
33.6
|
0.4
|
C12
|
B:R711630
|
2.8
|
49.6
|
0.6
|
C10
|
B:R711630
|
2.9
|
49.6
|
0.6
|
C10
|
B:R711630
|
3.1
|
33.6
|
0.4
|
CA
|
B:ALA170
|
3.6
|
16.4
|
1.0
|
CB
|
B:ALA170
|
3.6
|
24.2
|
1.0
|
C13
|
B:R711630
|
4.1
|
33.6
|
0.4
|
CG2
|
B:VAL440
|
4.1
|
14.5
|
1.0
|
C13
|
B:R711630
|
4.2
|
49.6
|
0.6
|
C9
|
B:R711630
|
4.2
|
49.6
|
0.6
|
C9
|
B:R711630
|
4.3
|
33.6
|
0.4
|
O
|
B:ALA170
|
4.5
|
16.4
|
1.0
|
O
|
B:HOH2066
|
4.5
|
3.4
|
1.0
|
C
|
B:ALA170
|
4.5
|
16.4
|
1.0
|
N
|
B:ALA170
|
4.5
|
16.4
|
1.0
|
CD1
|
B:TRP169
|
4.6
|
12.7
|
1.0
|
CZ
|
B:PHE129
|
4.6
|
20.0
|
1.0
|
O
|
B:GLU439
|
4.7
|
48.5
|
1.0
|
C8
|
B:R711630
|
4.7
|
49.6
|
0.6
|
C8
|
B:R711630
|
4.8
|
33.6
|
0.4
|
CE2
|
B:PHE434
|
4.8
|
29.2
|
1.0
|
CB
|
B:THR173
|
4.9
|
9.9
|
1.0
|
O
|
B:TRP169
|
5.0
|
19.7
|
1.0
|
|
Bromine binding site 4 out
of 6 in 1gsz
Go back to
Bromine Binding Sites List in 1gsz
Bromine binding site 4 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br1630
b:33.6
occ:0.38
|
BR23
|
B:R711630
|
0.0
|
33.6
|
0.4
|
BR23
|
B:R711630
|
1.0
|
49.6
|
0.6
|
C11
|
B:R711630
|
1.9
|
33.6
|
0.4
|
C11
|
B:R711630
|
2.1
|
49.6
|
0.6
|
C12
|
B:R711630
|
2.8
|
33.6
|
0.4
|
C10
|
B:R711630
|
2.9
|
49.6
|
0.6
|
C10
|
B:R711630
|
2.9
|
33.6
|
0.4
|
C12
|
B:R711630
|
3.1
|
49.6
|
0.6
|
CZ
|
B:PHE129
|
3.7
|
20.0
|
1.0
|
CE2
|
B:PHE434
|
4.0
|
29.2
|
1.0
|
CA
|
B:ALA170
|
4.2
|
16.4
|
1.0
|
C9
|
B:R711630
|
4.2
|
49.6
|
0.6
|
C13
|
B:R711630
|
4.2
|
33.6
|
0.4
|
C9
|
B:R711630
|
4.2
|
33.6
|
0.4
|
CE2
|
B:PHE129
|
4.2
|
20.0
|
1.0
|
O
|
B:HOH2066
|
4.2
|
3.4
|
1.0
|
C13
|
B:R711630
|
4.3
|
49.6
|
0.6
|
CB
|
B:ALA170
|
4.4
|
24.2
|
1.0
|
CG2
|
B:THR173
|
4.4
|
9.9
|
1.0
|
CB
|
B:THR173
|
4.4
|
9.9
|
1.0
|
O
|
B:ALA170
|
4.6
|
16.4
|
1.0
|
C8
|
B:R711630
|
4.7
|
33.6
|
0.4
|
CE1
|
B:PHE129
|
4.7
|
20.0
|
1.0
|
C8
|
B:R711630
|
4.8
|
49.6
|
0.6
|
OG1
|
B:THR173
|
4.8
|
9.9
|
1.0
|
CZ
|
B:PHE434
|
4.8
|
29.2
|
1.0
|
CG2
|
B:VAL440
|
4.9
|
14.5
|
1.0
|
C
|
B:ALA170
|
4.9
|
16.4
|
1.0
|
CD2
|
B:PHE434
|
4.9
|
29.2
|
1.0
|
|
Bromine binding site 5 out
of 6 in 1gsz
Go back to
Bromine Binding Sites List in 1gsz
Bromine binding site 5 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 5 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Br1630
b:34.2
occ:0.62
|
BR23
|
C:R711630
|
0.0
|
34.2
|
0.6
|
BR23
|
C:R711630
|
1.0
|
55.8
|
0.4
|
C11
|
C:R711630
|
1.9
|
34.2
|
0.6
|
C11
|
C:R711630
|
2.2
|
55.8
|
0.4
|
C12
|
C:R711630
|
2.8
|
34.2
|
0.6
|
C10
|
C:R711630
|
2.9
|
34.2
|
0.6
|
C12
|
C:R711630
|
2.9
|
55.8
|
0.4
|
C10
|
C:R711630
|
3.2
|
55.8
|
0.4
|
CA
|
C:ALA170
|
3.7
|
8.9
|
1.0
|
CB
|
C:ALA170
|
3.7
|
30.6
|
1.0
|
C13
|
C:R711630
|
4.2
|
34.2
|
0.6
|
C9
|
C:R711630
|
4.2
|
34.2
|
0.6
|
CG2
|
C:VAL440
|
4.2
|
12.0
|
1.0
|
O
|
C:HOH2056
|
4.2
|
20.2
|
1.0
|
C13
|
C:R711630
|
4.3
|
55.8
|
0.4
|
C9
|
C:R711630
|
4.4
|
55.8
|
0.4
|
CZ
|
C:PHE129
|
4.4
|
10.2
|
1.0
|
O
|
C:ALA170
|
4.5
|
8.9
|
1.0
|
C
|
C:ALA170
|
4.6
|
8.9
|
1.0
|
CE2
|
C:PHE434
|
4.6
|
35.0
|
1.0
|
N
|
C:ALA170
|
4.6
|
8.9
|
1.0
|
C8
|
C:R711630
|
4.7
|
34.2
|
0.6
|
CD1
|
C:TRP169
|
4.7
|
14.2
|
1.0
|
CB
|
C:THR173
|
4.8
|
5.0
|
1.0
|
O
|
C:GLU439
|
4.8
|
52.6
|
1.0
|
C8
|
C:R711630
|
4.9
|
55.8
|
0.4
|
CE2
|
C:PHE129
|
4.9
|
10.2
|
1.0
|
OG1
|
C:THR173
|
5.0
|
5.0
|
1.0
|
|
Bromine binding site 6 out
of 6 in 1gsz
Go back to
Bromine Binding Sites List in 1gsz
Bromine binding site 6 out
of 6 in the Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 6 of Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Br1630
b:55.8
occ:0.38
|
BR23
|
C:R711630
|
0.0
|
55.8
|
0.4
|
BR23
|
C:R711630
|
1.0
|
34.2
|
0.6
|
C11
|
C:R711630
|
1.9
|
55.8
|
0.4
|
C11
|
C:R711630
|
1.9
|
34.2
|
0.6
|
C10
|
C:R711630
|
2.8
|
55.8
|
0.4
|
C10
|
C:R711630
|
2.8
|
34.2
|
0.6
|
C12
|
C:R711630
|
2.9
|
55.8
|
0.4
|
C12
|
C:R711630
|
2.9
|
34.2
|
0.6
|
CZ
|
C:PHE129
|
3.5
|
10.2
|
1.0
|
CE2
|
C:PHE434
|
4.0
|
35.0
|
1.0
|
C9
|
C:R711630
|
4.1
|
34.2
|
0.6
|
C13
|
C:R711630
|
4.1
|
34.2
|
0.6
|
CE2
|
C:PHE129
|
4.1
|
10.2
|
1.0
|
C9
|
C:R711630
|
4.2
|
55.8
|
0.4
|
C13
|
C:R711630
|
4.2
|
55.8
|
0.4
|
O
|
C:HOH2056
|
4.2
|
20.2
|
1.0
|
CA
|
C:ALA170
|
4.2
|
8.9
|
1.0
|
CG2
|
C:THR173
|
4.2
|
5.0
|
1.0
|
CB
|
C:THR173
|
4.3
|
5.0
|
1.0
|
CB
|
C:ALA170
|
4.5
|
30.6
|
1.0
|
OG1
|
C:THR173
|
4.5
|
5.0
|
1.0
|
CE1
|
C:PHE129
|
4.6
|
10.2
|
1.0
|
O
|
C:ALA170
|
4.6
|
8.9
|
1.0
|
C8
|
C:R711630
|
4.6
|
34.2
|
0.6
|
C8
|
C:R711630
|
4.7
|
55.8
|
0.4
|
CZ
|
C:PHE434
|
4.8
|
35.0
|
1.0
|
C
|
C:ALA170
|
4.9
|
8.9
|
1.0
|
CD2
|
C:PHE434
|
5.0
|
35.0
|
1.0
|
O
|
C:HOH2054
|
5.0
|
9.7
|
1.0
|
|
Reference:
A.Lenhart,
W.A.Weihofen,
A.E.W.Pleschke,
G.E.Schulz.
Crystal Structure of A Squalene Cyclase in Complex with the Potential Anticholesteremic Drug RO48-8071 Chem.Biol. V. 9 639 2002.
ISSN: ISSN 1074-5521
PubMed: 12031670
DOI: 10.1016/S1074-5521(02)00138-2
Page generated: Wed Jul 10 16:34:51 2024
|